See you at ESCMID Global 2025
Join us at Ecraid’s exhibition booth E70 at ESCMID Global 2025 in Vienna. Once again, we will catch up with collaborators from across Europe, meet new colleagues, and showcase our research and educational efforts. Look for presentations by our affiliated experts and studies, as well as the annual Young Investigator Workshop.
From 11 to 15 April, thousands of academia, healthcare, industry, and health authority representatives will come together at the Messe Wien Exhibition & Congress Center and online for the 35th congress of the European Society of Clinical Microbiology & Infectious Diseases (ESCMID).
Meet the Ecraid team
Our clinical and laboratory network representatives, operational team, and Business Development colleagues will be at the Ecraid booth, ready to meet you. We look forward to catching up with long-time partners and collaborators and meeting new colleagues from the field.
You will find us at booth E70 in Hall B. Click here for a larger version of the floor plan.
Want to schedule a meeting in advance? Get in touch.
Young Investigator Workshop
Ecraid’s Young Investigator Workshop will take place during ESCMID Global for the fourth year running. Our young ambassadors from France, Italy, the Netherlands, and Switzerland will share valuable experience from their work on Ecraid's perpetual observational studies, focusing on methodology and network building. Participants will be encouraged to ask questions and share their own learnings.
The one-hour hybrid workshop will take place on Sunday, 13 April from 10:00 CET in room Schubert 3 of the congress center. Attendance is free with a valid ticket for ESCMID Global 2025; however, advance registration is required.
Planning to join onsite or online? Let us know.
Scientific programme
Ecraid is co-organising a session, with our network of experts and studies featured in ESCMID Global’s scientific programme.
Friday, 11 April
Special Session: Antimicrobial Stewardship in Different Scenarios
Co-chaired by Oana Sandulescu (Romania)
08:30 - 10:30 CET, Hall 0
Special Session: Top Five Mistakes in Infection Prevention and Control
Co-chaired by Arjana Tambic Andrasevic (Croatia)
13:30 - 14:30 CET, Hall 0
Special Session: Science Slam - How to Communicate Science with Clarity
Co-chaired by Jesús Rodríguez-Baño (Spain)
14:45 - 15:45 CET, Hall 0
Saturday, 12 April
ePoster Flash Session: Emerging Developments in Antifungal Pharmacology
Chaired by Roger Brüggemann, Ecraid P3 Network (Netherlands)
09:30 - 10:30, Arena 4
Symposium: Year in Infectious Diseases
Co-chaired by Ecraid COO Evelina Tacconelli (Italy)
13:30 - 14:30 CET, Hall 1
Symposium: Macrolides in Community-Acquired Pneumonia: Therapeutic Necessity or Path to Overuse?
Co-chaired by Ecraid CEO Marc Bonten (Netherlands)
14:45 - 15:45 CET, Hall 2
Constructing your Manuscript for an Original Article
16:15 - 18:15 CET, Hall 15
Presented by Jesús Rodríguez-Baño (Spain) at the Educational Session: The rare art of writing scientific articles: from conception to submission, chaired by Marlieke De Kraker (Switzerland) and Mical Paul (Israel).
Benzylpenicillin versus (Flu)cloxacillin for the Treatment of Penicillin-Susceptible Staphylococcus Aureus Bacteraemia: a Randomised Controlled trial of the S. Aureus Network Adaptive Platform.
16:15 - 18:15 CET, Hall 13
Steven Tong (Australia) will speak at the Oral Session: The Trial Run: recent trials on S. aureus bacteraemia management, co-chaired by Vance Fowler (United States).
Sunday, 13 April
Improved Clinical Trials in Community-Acquired Pneumonia using Precision Medicine
08:30 - 10:30 CET, Hall 2
Presentation by Lennie Derde (Netherlands) during the Educational Session: New tools in acute bacterial infections and sepsis: from machine learning to precision medicine, co-organised by Ecraid.
The Rise of Anti-Science: Lessons for the Future Scientist
11:00 - 12:00 CET, Hall 6
Marion Koopmans (Netherlands) will give a 30-min presentation during the Symposium: How to address anti-science in our community?
Antibiotic Treatment Duration of Complicated Uurinary Tract Infection Patients in Europe: Results from the Ecraid POS-cUTI study
11:00 - 12:00 CET, Hall 11
The ECRAID-Base POS-cUTI project team will present their results during the Oral Session: Clinical studies in UTI, co-chaired by Iva Butic (Croatia)
Keynote Lecture: Tuberculosis: Where are we now and Where should we be
Presented by Ecraid Scientific Advisory Board member, Guy Thwaites (Vietnam).
16:15 - 17:15 CET, Hall 1
Why does Rabies Virus not Induce an Anti-Viral Immune Response: Insights from Experimental Models and a Human Cohort
Presented by members of the ECRAID-Base POS-Disease X project during the Oral Session: Heterogeneity and complexity of sepsis, co-chaired by Despoina Koulenti (Greece).
16:15 - 18:15 CET, Hall 13
Oral Session: Trials in Severe Infections
Chaired by Lennie Derde (Netherlands) and Steven Tong (Australia)
16:15 - 18:15 CET, Hall 9
Monday, 14 April
The Concept of Complicated UTI: The Site of Infection Matters Most
11:00 - 12:00 CET, Hall 13
Presented by Jesús Rodríguez-Baño during the Symposium: Why is the concept of complicated UTI so complicated?
Ventilator-Associated Pneumonia (VAP) and ICU Environment: How Can We Improve Practices?
11:00 - 12:00 CET, Hall 4
Presentation by Despoina Koulenti during the Symposium: Infection prevention and control and intensive care: challenges and solutions.
Yes: Antibacterial Resistance Threatens Medical Outcomes
14:45 - 15:45 CET, Hall 12
Presentation by Evelina Tacconelli during the Pipeline Symposium: Do we need new antibiotics?
Excellence Award Lecture: Towards Pandemic Prevention, Moonshot or Utopia?
16:15 - 17:30 CET, Hall 1
Lecture by Marion Koopmans, to commemorate her ESCMID Outstanding Contributions in the Field of Infection award 2025.
Tuesday, 15 April
Using mathematical and epidemiological models to identify the drivers of AMR
2-hour Symposium chaired by Marc Bonten.
08:30 - 10:30 CET, Hall 14
Ecraid’s perpetual observational study on ventilator-associated pneumonia (POS-VAP): empirical treatment practices across Europe
Poster presentation by Holly Jackson (Switzerland) during Poster Session 08d Healthcare-associated pneumonia (incl VAP).
12:00 - 13:30 CET, Poster Area